Key points are not available for this paper at this time.
ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTMetallodrugs in Medicinal Inorganic ChemistryKatja Dralle Mjos and Chris Orvig*View Author Information Medicinal Inorganic Chemistry Group, Department of Chemistry, The University of British Columbia, 2036 Main Mall, Vancouver, British Columbia V6T 1Z1, Canada*E-mail: email protectedCite this: Chem. Rev. 2014, 114, 8, 4540–4563Publication Date (Web):January 23, 2014Publication History Received21 August 2013Published online23 January 2014Published inissue 23 April 2014https://doi.org/10.1021/cr400460sCopyright © 2014 American Chemical SocietyRIGHTS & PERMISSIONSACS AuthorChoiceArticle Views54643Altmetric-Citations837LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit PDF (3 MB) Get e-AlertsSUBJECTS:Cancer,Cancer therapy,Ions,Metals,Pharmaceuticals Get e-Alerts
Mjos et al. (2014) studied this question.